Results 81 to 90 of about 1,129 (187)

Critical evaluation of the efficacy and tolerability of azilsartan

open access: yesVascular Health and Risk Management, 2012
Alberto R De Caterina1,2, Andrew R Harper2,3, Florim Cuculi21Istituto Scienze della Vita, Scuola Superiore Sant'Anna, Pisa, Italy; 2Oxford University Hospitals, Oxford; 3Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne ...
Cuculi F, Harper AR, De Caterina AR
doaj  

GW27-e0799 Safety of azilsartan medoxomil in hypertension: A Meta-analysis

open access: yesJournal of the American College of Cardiology, 2016
This study was to compare the safety in patients with hypertension receiving azilsartan medoxomil as monotherapy or other antihypertensive agents. The Cochrane library, PubMed, Chinese National Knowledge Infrastructure(CNKI), Wanfang Data were searched from the beginning of the records ...
Zhang Panxiao   +3 more
openaire   +1 more source

Solid State Form of Azilsartan Kamedoxomil and Process for its Preparation [PDF]

open access: yes, 2020
Provided herein is a solid state form of Azilsartan kamedoxomil and process for its ...
, Srinivasan Thirumalai Rajan
core   +1 more source

Clinical utility of azilsartan–chlorthalidone fixed combination in the management of hypertension [PDF]

open access: yes
Azilsartan–chlorthalidone fixed combination is a new drug in the management of hypertension. Azilsartan has been shown to have greater blood pressure-lowering effects than other angiotensin-receptor blockers (ARBs), and the debate regarding the ...
Bleske, Barry E   +2 more
core   +2 more sources

Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I–II essential hypertension: a randomized, double-blind clinical study [PDF]

open access: yes
Azilsartan is a novel angiotensin receptor blocker being developed for hypertension treatment. This 16-week, multicenter, randomized, double-blind study compared the efficacy and safety of azilsartan (20–40 mg once daily by forced titration) and its ...
B Dahlof   +24 more
core   +2 more sources

The antihypertensive activity of benzimidazoles and the binding of its derivatives to the AT1 receptor [PDF]

open access: yes, 2021
For å undersøke den antihypertensive effekten til benzimidazol derivater og effekten av ulike substituenter, på benzimidazol kjernemolekylet, på den antihypertensive effekten vil denne oppgaven se på bindingen av inverse agonister og agonister til AT1 ...
Aracena-Solem, Matias
core  

Modern approaches to the treatment and long-term management of arterial hypertension in clinical practice. Pharmacological and clinical characteristics of angiotensin II receptor blockers: focus on azilsartan medoxomil. Part II

open access: yesКардиоСоматика, 2015
The article discusses the problem of the use for the treatment of hypertension combination therapy. Advantages of application as a component of chlorthalidone therapy are discussed.
M. G Bubnova
doaj  

IMMEDIATE RELEASE SOLID DISPERSION TABLET OF AZILSARTAN: FORMULATION STRATEGY TO ENHANCE ORAL BIOAVAILABILITY [PDF]

open access: yes, 2020
Objective: Objective of the present study was to develop an immediate release solid dispersion tablet to enhance oral bioavailability of Azilsartan. Methods: Solid dispersion of azilsartan was developed using Soluplus® as a novel solubility enhancer by ...
MOHITE, SHRINIVAS K., TAMBOLI, JAMEER A.
core   +1 more source

Development and validation of UV Spectrophotometric method for simultaneous estimation of Efonidipine hydrochloride ethanolate and Chlorthalidone in their synthetic mixture [PDF]

open access: yes, 2022
Efonidipine Hydrochloride Ethanolate and Chlorthalidone is used in management of hypertension and under clinical phase 3 study. The development of quality control method is required for accurate analysis of both drugs.
Meshram, Dhananjay   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy